Pressure BioSciences's revenue for the
three
months ended in Sep. 2023 was $0.41 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $2.27 Mil.
Pressure BioSciences's Revenue per Share for the
three
months ended in Sep. 2023 was $0.02.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.14.
Warning Sign:
Pressure BioSciences Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Pressure BioSciences was -6.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -44.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -41.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -26.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Pressure BioSciences's highest 3-Year average Revenue per Share Growth Rate was 125.40% per year. The lowest was -78.50% per year. And the median was -14.20% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pressure BioSciences's Revenue
For the Medical Devices subindustry, Pressure BioSciences's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pressure BioSciences's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's Revenue distribution charts can be found below:
* The bar in red indicates where Pressure BioSciences's Revenue falls into.
Pressure BioSciences Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Pressure BioSciences Revenue Related Terms
Thank you for viewing the detailed overview of Pressure BioSciences's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Pressure BioSciences (Pressure BioSciences) Business Description
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBIO has been successfully added to your 